Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Conducting Inline Microbial Testing of Cream Products – V 2.0

Posted on By

Creams: SOP for Conducting Inline Microbial Testing of Cream Products – V 2.0

Standard Operating Procedure for Conducting Inline Microbial Testing of Cream Products

Department Creams
SOP No. SOP/CRM/179/2025
Supersedes SOP/CRM/179/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for conducting inline microbial testing during the cream manufacturing process. This ensures that the microbial contamination levels in cream products are controlled and within regulatory limits, ensuring product safety and compliance.

2. Scope

This SOP applies to all inline microbial testing performed during the manufacturing of cream products. It includes the testing of cream samples for microbial contamination and the procedures for ensuring compliance with microbiological standards.

3. Responsibilities

  • Production Team: Responsible for ensuring that microbial testing is performed at the specified intervals and that all necessary samples are taken during production.
  • Quality Control (QC) Team: Responsible for conducting microbial testing, analyzing results, and ensuring that the product meets microbial standards before it moves forward in the production process.
  • Quality Assurance (QA) Team: Responsible for overseeing the microbial testing process and ensuring compliance with SOPs, regulatory requirements, and quality standards.
  • Laboratory Supervisor: Responsible for ensuring that microbial
testing is conducted in accordance with the SOP, ensuring equipment calibration, and verifying test results.

4. Accountability

The Production Manager is accountable for ensuring that inline microbial testing is conducted as per this SOP and that the samples are collected at appropriate intervals. The QC Manager is responsible for overseeing the testing and reviewing the results. The Laboratory Supervisor is accountable for ensuring the proper calibration and functionality of microbial testing equipment.

5. Procedure

5.1 Pre-Production Setup

  1. Ensure that all required equipment for microbial testing, such as petri dishes, agar media, incubators, and swab kits, are available and functional before the start of production.
  2. Verify that the microbial testing equipment is calibrated according to the manufacturer’s instructions and complies with GMP requirements.
  3. Review the Batch Manufacturing Record (BMR) to ensure the specific microbial testing points, sample sizes, and testing intervals are clearly outlined and understood by the production and QC teams.

5.2 Sample Collection for Microbial Testing

  1. During production, collect microbial samples from designated points in the production process, such as during mixing, after heating, or before packaging, as specified in the BMR.
  2. Use sterile sampling methods, including sterile swabs or containers, to ensure that the samples are free from external contamination.
  3. Record the sample collection time, batch number, operator name, and other relevant details in the Microbial Testing Log (Annexure-1).
  4. Ensure that the samples are properly labeled with batch numbers and sample points to ensure traceability.

5.3 Performing Microbial Testing

  1. Test the collected samples for microbial contamination using appropriate methods, such as agar plate count, membrane filtration, or rapid testing methods, as per regulatory guidelines.
  2. Incubate samples at the appropriate temperature and for the specified time, following the standard procedures outlined in the BMR.
  3. Monitor the growth of microbial colonies on the agar plates or other testing media and record the results, including the number of colonies and any microbial identification, if applicable.
  4. Compare the microbial count results to the acceptable limits outlined in the product specification and regulatory requirements.

5.4 Handling Deviations

  1. If microbial contamination exceeds acceptable limits, stop production immediately and investigate the cause of the contamination.
  2. Determine whether the contamination is due to equipment, raw materials, environmental factors, or personnel practices.
  3. Take corrective actions to eliminate the source of contamination, which may include equipment sanitization, improving hygiene practices, or changing raw materials.
  4. Document all deviations and corrective actions in the Deviation Report (Annexure-2) and ensure that the report is reviewed and signed by the QA team before production resumes.

5.5 Post-Production Activities

  1. Once microbial testing is completed and all results meet acceptable limits, approve the batch for the next stage in production, such as packaging and labeling.
  2. Ensure that all test results are documented in the Microbial Testing Log (Annexure-1) and reviewed for completeness and accuracy by the QC team.
  3. Store all microbial test results for future reference and audits, maintaining records for at least two years or as required by regulatory guidelines.

5.6 Documentation and Record-Keeping

  1. Document all microbial testing activities, including sample collection, testing results, corrective actions, and approvals, in the Microbial Testing Log (Annexure-1).
  2. Ensure that any deviations from the microbial testing standards are documented in the Deviation Report (Annexure-2), with a description of the problem, corrective actions, and resolution.
  3. Ensure that all records are reviewed by the QC team for accuracy and completeness. Store all documentation in compliance with GMP requirements for traceability and auditing purposes.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Microbial Testing Log
  2. Annexure-2: Deviation Report

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Microbial Control in Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Microbial Testing Log

Batch Number Sample Point Collection Time Test Method Result Operator Remarks
12345 Mixing Tank 09:00 AM Agar Plate Count No Growth John Doe Within specifications
12345 Post-Heating 09:30 AM Membrane Filtration No Growth Jane Smith Within specifications
12345 Pre-Packaging 10:00 AM Agar Plate Count 3 CFU Michael Lee Acceptable, corrective action not required
12345 Post-Packaging 10:30 AM Agar Plate Count 12 CFU Michael Lee Above acceptable limit, batch rejected

Annexure-2: Deviation Report

Batch Number Deviation Description Corrective Action Resolved By
12345 Microbial contamination detected in post-packaging sample Batch rejected, cleaned equipment, re-sampled QA Head

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Sampling and Testing Bulk Creams before Filling - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Operation of Lyophilizers in Injectable Production – V 2.0
Next Post: Biosimilars: SOP for Oxygen Enrichment Protocols – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version